Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5 / ACCORD17): final results of a randomised, phase 2/3 trial - Conroy, T; Galais, M-P; Raoul, J-L (Lancet Oncol, 2014)
et al.